Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aline Moignet

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Blood Advances|November 5, 2025
Diagnostic Criteria for NK-Cell Large Granular Lymphocyte Leukemia: Validation Through a Multicentric International StudyCedric Pastoret, Jun Yang, David J Feith, et al.
Hematological Oncology|February 21, 2025
Remote Monitoring of CAR T-Cell Treated Patients by a Specialized Nurse to Detect and Manage Late Complications: Report of the CARAMA ProgramFanny Colin, Adeline Bellec, Laetitia Le Bars, et al.
Blood|January 29, 2021
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cellsCédric Pastoret, Fabienne Desmots, Gaëlle Drillet, et al.
British Journal of Haematology|April 19, 2024
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemiaTony Marchand, Cédric Pastoret, Gandhi Damaj, et al.
Hemasphere|May 28, 2024
Remission after CAR T-cell therapy: Do lymphoma patients recover a normal life?Alya Perthus, Fanny Colin, Emilie Charton, et al.
Oncotarget|October 6, 2017
<i>STAT3</i> mutation impacts biological and clinical features of T-LGL leukemiaAntonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.
Blood|August 12, 2015
Severe chronic primary neutropenia in adults: report on a series of 108 patientsFlore Sicre de Fontbrune, Aline Moignet, Blandine Beaupain, et al.
Blood|October 30, 2024
Long-term follow-up of the STOPAGO studyAdrien Cottu, Stéphanie Guillet, Jean-François Viallard, et al.
Hemasphere|January 22, 2025
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSAAmira Marouf, Sammara Chaubard, Raphaël Liévin, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Blood Advances|November 5, 2025
Diagnostic Criteria for NK-Cell Large Granular Lymphocyte Leukemia: Validation Through a Multicentric International StudyCedric Pastoret, Jun Yang, David J Feith, et al.
Hematological Oncology|February 21, 2025
Remote Monitoring of CAR T-Cell Treated Patients by a Specialized Nurse to Detect and Manage Late Complications: Report of the CARAMA ProgramFanny Colin, Adeline Bellec, Laetitia Le Bars, et al.
Blood|January 29, 2021
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cellsCédric Pastoret, Fabienne Desmots, Gaëlle Drillet, et al.
British Journal of Haematology|April 19, 2024
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemiaTony Marchand, Cédric Pastoret, Gandhi Damaj, et al.
Hemasphere|May 28, 2024
Remission after CAR T-cell therapy: Do lymphoma patients recover a normal life?Alya Perthus, Fanny Colin, Emilie Charton, et al.
Oncotarget|October 6, 2017
<i>STAT3</i> mutation impacts biological and clinical features of T-LGL leukemiaAntonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.
Blood|August 12, 2015
Severe chronic primary neutropenia in adults: report on a series of 108 patientsFlore Sicre de Fontbrune, Aline Moignet, Blandine Beaupain, et al.
Blood|October 30, 2024
Long-term follow-up of the STOPAGO studyAdrien Cottu, Stéphanie Guillet, Jean-François Viallard, et al.
Hemasphere|January 22, 2025
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSAAmira Marouf, Sammara Chaubard, Raphaël Liévin, et al.
Pageof 2